Online therapy to help youth at risk for psychosis
Part of Mental health clinical trials.
This trial tests a telehealth (video/phone) version of cognitive behavioral therapy to help young people who are at risk for developing psychosis. It may help by teaching skills to reduce symptoms and improve coping, with support from a key family or close person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 25 years old
- You can take part in study visits and therapy in English
- A clinician says you meet “at-risk for psychosis” criteria (using the SIPS checklist)
- If you take psychiatric medicines, your dose has been stable for at least 1 month (no changes)
- You have one important person in your life who can join—at least 4 hours per week contact and they are willing to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new program to help young people who have early signs of psychosis and have had thoughts of suicide or tried to harm themselves. The program works with the young person and a family member or caregiver to improve support and reduce suicide risk.
This study tests a digital version of dialectical behavioural therapy (a type of talk therapy) to help young people who have early signs of psychosis. It aims to see if this therapy can reduce symptoms and improve well-being.
This study tests a support program for young people in Tunisia who show early signs of possible psychosis. It aims to help them before more serious symptoms develop.
This study explores how young people who are at high risk for psychosis or have had a first episode experience mindfulness. It uses interviews to understand their personal experience, which could help improve future treatments.
This study tests whether a mindfulness program can help prevent psychosis in young people who are at ultra high risk. The goal is to see if learning mindfulness skills can protect your mental health and keep symptoms from getting worse.
This study tests whether a medication called cannabidiol (a non-intoxicating compound from cannabis) can help reduce symptoms and prevent progression in young people at clinical high risk for psychosis. Participants will receive either the study drug or a placebo (a pill with no active ingredient) and will be followed to see how they respond.
Hear when a new Clinical High Risk for Psychosis (CHR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.